We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




AI Assistance Improves Breast-Cancer Screening by Reducing False Positives

By HospiMedica International staff writers
Posted on 11 Apr 2024

Radiologists typically detect one case of cancer for every 200 mammograms reviewed. More...

However, these evaluations often result in false positives, leading to unnecessary patient recalls for additional testing, which not only causes patient anxiety but also consumes valuable medical resources. Now, a new study has shown how artificial intelligence (AI) can improve the accuracy of breast cancer screening by minimizing these false positives without missing true positives.

The study by researchers at Washington University School of Medicine in St. Louis (St. Louis, MO, USA) and Whiterabbit.ai (Santa Clara, CA, USA) builds on their previous collaboration for the development of an AI algorithm to help radiologists assess breast density on mammograms for identifying people who stand to benefit from additional or alternative screening. That algorithm is marketed by Whiterabbit.ai as WRDensity after receiving clearance from the Food and Drug Administration (FDA) in 2020.

In the current study, the team developed an algorithm to identify normal mammograms with extremely high sensitivity. They went on to run a simulation on patient data to see what would have happened if all of the very low-risk mammograms were taken off the radiologists’ plates, allowing the doctors to focus on the more questionable scans. The results of this simulation indicated that such an approach would reduce the number of unnecessary patient callbacks for additional testing, yet maintain the same rate of cancer detection.

“At the end of the day, we believe in a world where the doctor is the superhero who finds cancer and helps patients navigate their journey ahead,” said Jason Su, co-founder and chief technology officer at Whiterabbit.ai. “The way AI systems can help is by being in a supporting role. By accurately assessing the negatives, it can help remove the hay from the haystack so doctors can find the needle more easily. This study demonstrates that AI can potentially be highly accurate in identifying negative exams. More importantly, the results showed that automating the detection of negatives may also lead to a tremendous benefit in the reduction of false positives without changing the cancer detection rate.”

Related Links:
WUSTL
Whiterabbit.ai


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hypodermic Syringe
SurTract™ Safety Syringe
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Illustration of the Hēlo Thrombectomy System device (Photo courtesty of Endovascular Engineering)

FDA-Cleared Thrombectomy System Removes Pulmonary Embolism Clots

Pulmonary embolism occurs when blood clots travel to the lungs and block blood flow, potentially requiring urgent endovascular intervention to prevent death. Catheter-based clot removal can be challenging,... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.